Population
Normal adolescent male CD-1 or C3H/HeJ mice and cultured murine cardiac fibroblasts
Design
Preclinical
Authors
Loading...
Raises caution for antibody therapies targeting CVB3; leaves open whether molecular mimicry sustains chronic human myocarditis.
The study provides preclinical evidence that molecular mimicry via anti-CVB3 neutralizing antibodies can sustain chronic inflammation in myocarditis.
Gauntt et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: